surmount 5 tirzepatide SURMOUNT-5 (NCT05822830) was a multi-center, randomized, open-label, phase 3b trial evaluating the efficacy and safety of #Zepbound® (tirzepatide) compared with #Wegovy® (semaglutide, similar to full dose #ozempic) in adults with obesity + Can one obesity medication deliver

MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming

We're so confident in our personalized program and care, if you're not completely satisfied within 30 days, we'll refund your money

These medications are generally recommended for individuals who are overweight or obese, especially if they have additional health risks like type 2 diabetes or metabolic syndrome

The oak wood intervention also resulted in significant improvement in the liver enzymes AST and ALT, and in the liver fibrosis index, compared to the standard management group

This pathway is separate from and synergistic with the GHRH pathway

Journal of Thoracic and Cardiovascular Surgery 169: e18, 2025